The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: INFLIXIMAB, RECOMBINANT     Injury: Clostridium difficile infection     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 5     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
121196902 INFLIXIMAB, RECOMBINANT Clostridium difficile infection JANSSEN 47.00 YR M 78 KG 20160718 FR
124892872 INFLIXIMAB, RECOMBINANT Clostridium difficile infection JANSSEN 31.00 YR M 0 20160802 CA
125288884 INFLIXIMAB, RECOMBINANT Clostridium difficile infection JANSSEN 18.85 YR F 47 KG 20160728 US
126417881 INFLIXIMAB, RECOMBINANT Clostridium difficile infection JANSSEN 21.41 YR M 83 KG 20160810 US
126594331 INFLIXIMAB, RECOMBINANT Clostridium difficile infection JANSSEN 0.00 0 20160817 CA

  |<   1/2   << Previous Page   Page 1  

Total Records: 5     Number of Pages: 1

Execution Time: 0.014312028884888 seconds (ucode:5188955). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.